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IN a recent publication (Bennett and Millett, 1969) an account was given of a
characteristic type offibrous banding or nodular sclerosis seen in lymph nodes from
some patients with lymphosarcoma. These features were associated with a rela-
tively good prognosis, compared with other histological types of lymphosarcoma,
especially in patients presenting with generalised disease.
The number of patients in the original survey was small and the investigation
has been continued to increase the total number of patients studied.
CLINICAL MATERIAL
The present survey includes the 185 patients in the original series reported from
Mount Vernon Hospital to which have been added 140 patients diagnosed as suffer-
ing from lymphosarcoma or one of its variants, seen in the Middlesex Hospital
Radiotherapy Department between 1948 and 1968. Patients have been excluded
from the series only ifthe original histological material was no longer available or
the follow up inadequate.
The combined total of 325 patients has been reviewed. Ninety-two cases have
been excluded, 39 because the histological diagnosis was considered to be either
reticulum cell sarcoma or anaplastic carcinoma, 34 because a careful search
demonstrated Reed-Sternberg cells, indicating a diagnosis of Hodgkin's disease,
and 19 because the lymphosarcoma had apparently originated in extra-nodal sites.
A total of 233 patients with lymphosarcoma arising primarily in the lymph
nodes remained for review. Fifty-nine of these had been treated within the past
5 years, leaving 174 possible 5 year survivors (Table I). This number was small
and division of patients into 4 different clinical stages would have been of limited
value. Consequently cases have been staged only as " localised " (Stages I, II,
Rye classification, Rosenberg, 1966) or " generalised " (Stages III, IV, Rye
classification).
TABLE I.-Analysis of 325 Patients Reviewed During Present Survey
All patients reviewed . . . . . 325
Excluded
(1) Hodgkin's disease . . . . 34
(2) Other diagnoses . . . . . 39
(3) Extranodal origin . . . . . 19
Total excluded . . . . . . 92
All patients with primary nodal lymphosarcoma . 233
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HISTOLOGICAL CLASSIFICATION
Paraffin sections ofthe original pre-treatment lymph node biopsy and autopsy
specimens, when available, were stainedroutinely with haematoxylin and eosin and
where possible for reticulin fibres.
The same histological classification described in the earlier report (Bennett and
Millett, 1969) has been used.
1. Follicular lymphoma
The criteria adopted by Rappaport (1963) and Harrison (1966) were used to
distinguish follicular lymphoma from lymph nodes showing reactive hyperplasia.
All nodes in this group showed a uniform follicular pattern replacing the normal
architecture throughout the whole node. Further subdivision according to the cell
type was not performed asitisgenerallyagreedthatallformsoffollicularlymphoma
have a better prognosis than the diffuse forms whatever the cytological type.
Extra capsular infiltration was present in all lymph nodes in which portions of
capsule were examined and it was not considered to be an indication ofprogression
to diffuse lymphosarcoma. Fibrosis was absent or minimal.
2. Diffuse lymphosarcoma
The nodal architecture was replaced diffusely by cells of the lymphoid series,
either small mature lymphocytes or larger more immature lymphoid cells, or a
mixture oflymphoid cells ofvariable maturity. Part of a single node or one of a
group of nodes sometimes showed a follicular pattern but when the replacement
was predominantly of a diffuse pattern it was classified as diffuse lymphosarcoma.
Extracapsular infiltration was present in nearly all lymph nodes in which portions
ofthe capsule were included and no significance could be attached to this finding.
Fibrosis was absent or minimal.
3. Lymphoblastic lymphosarcoma
Inthis groupthenodalpatternwas diffuse butthelymphoid cells wereprimitive
in type and often showed obvious nucleoli. Scattered phagocytic histiocytic cells,
associated with a " starry sky " appearance, were sometimes present. Fibrosis
was minimal or absent.
4. Nodular sclerotic lymphosarcoma
As described previously, nodular sclerotic lymphosarcoma was characterised by
prominent fibrous bands which divided up part or all of the lymph node. These
bands varied in thickness from 10 ,u to several hundred ,u, were doubly refractile
and contained many reticulin fibres. The background pattern was either that of
diffuse lymphosarcoma, follicular lymphoma or a combination of both. When
EXPLANATION OF PLATES
FIG. 1.-Follicular lymphoma pattern with fibrous bands. H. and E. x 14.
FIG. 2.-Diffuse lymphosarcomatous pattern with fibrous bands. H. and E. x 14.
FIG. 3.-Diffuse and follicular patterns divided by fibrous bands. H. and E. x 14.
FIG. 4.-Cellular component predominently mature lymphoid cells. H. and E. x 70.
FIG. 5.-Cellular component mature and immature lymphoid cells. H. and E. x 70.
FIG. 6.-Cellular component mainly immature lymphoid cells. H. and E. x 70.BRrTISH JOuiRNAL O0 CANCER.
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both diffuse and follicularpatterns were present in the same node, the follicles were
frequently small and ill-defined (Fig. 1-3).
The cellular component was variable. There was either a relatively uniform
pattern of mature or immature lymphoid cells, or a mixture of lymphoid cells of
different maturities, as in follicular lymphoma and diffuse lymphosarcoma (Fig.
4-6). Stem cells or reticulum cells were sometimes present, usually singly, and no
Reed-Sternberg cells were found despite prolonged searching. Invasion of peri-
capsular tissue was frequently present and in these areas the fibrous bands were
sometimes very prominent.
CLINICAL BEHAVIOUR AND MICROSCOPICAL FINDINGS
The pathological slides were examined by 2 ofus (M.H.B. and G.F-B.) with no
knowledge ofthe clinical details and the patients were placed in the above 4 histo-
logical groups solely on the microscopical appearances of the lymph nodes.
Sex distribution
The combined total of 233 patients with lymphosarcoma originating in lymph
nodes showed a similar sex distribution as in the series reported by Bennett and
Millett (male 133: female 100). Diffuse lymphosarcoma (male 57: female 30) and
lymphoblastic lymphosarcoma (male 26: female 15) occurred more commonly in
the male; follicular lymphoma (male 23: female 34) more commonly in the female,
while nodular sclerotic lymphosarcoma laybetween these groups in its sex distribu-
tion (male 27: female 21).
Age distribution
Examination ofthe whole group of 233 patients showed that there was a small
peak ofpatients in the second decade and a main larger peak between the fifth and
seventh decades (Fig. 7). Of 19 patients under the age of 20, the lymph nodes
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FIG. 7.-Distribution of 233 patients with lymphosarcoma according to age and sex.
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showed lymphoblastic or diffuse lymphosarcoma except in 4. Two of these 4
showed follicular lymphoma and 2 nodular sclerotic lymphosarcoma. Apart from
the patients referred to above, nodular sclerotic lymphosarcoma occurred in
patients over the age of 30 and the peak incidence was in the sixth and seventh
decades.
Factors influencing survival
Treatment.-All but a few patients in this group were referred for treatment to
one oftwo radiotherapy centres. Most ofthem were treated by radiotherapy but
rMV/H.
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FIG. 8. Five year survival curves of all patients with lymphosarcoma.
there was considerable variation in dosage and technique, while some received
cytotoxic drugs. Because ofthis variation, no attempt has been made to assess the
value of treatment.
Histologicalfintding8.-Theprognosis ofthe 174possible 5yearsurvivors,divided
into the 4histological groups, isindicatedinFig. 8. Sixty-four patients haddiffuse
lymphosarcoma, 43 follicular lymphoma, 30 lymphoblastic lymphosarcoma and
37 (21%) nodular sclerotic lymphosarcoma.
Lymphoblastic lymphosarcoma is generally regarded as highly malignant:
nevertheless, 3 patients survived 5 years. Comparable survival rates for diffuse
lymphosarcoma and follicular lymphoma were 36% and 42% respectively.
Patients with lymphosarcoma ofthe nodular sclerotic type had the best prognosis
with a 57% 5 year survival rate.NODULAR SCLEROTIC LYMPHOSARCOMA
Clinical stage.-The 174 possible 5 year survivors have been divided into those
with localised or generalised disease. This distribution ofpatients ofthe 4 histo-
logical types into localised and generalised groups when first seen gives some
indication ofthe variation in degree ofmalignancy ofthe different types (Table II).
Lymphoblastic lymphosarcoma presented as a localised disease in only 27% of
patients, whereas the disease was localised in 34% ofpatients with diffuse lympho-
sarcoma and 65% ofthose with nodular sclerotic lymphosarcoma. This suggests
that nodular sclerotic lymphosarcoma progresses slowly.
TABLE II.-Analysis of 174 Possible 5 Year Survivors According to Histological
Histological group
Lymphoblastic
Diffuse
Follicular lymphoma .
Nodular sclerotic
No. of
cases
30
64
43
37
Group and Extent of Disease
No. of
cases with
localised
disease % total
8
22
16
24
27%
34%
37%
65%
No. of
cases with
generalised
disease
22
42
27
13
% total
73%
66%
63%
35%
When the disease was generalised, the 5 year survival rate was closely related to
the histological type (Fig. 9). The 5yearsurvival rate ofnodular scleroticlympho-
sarcoma (38%) confirms that this entity is arelatively slowly progressive disease.
rMVH.
JULY 1969 COMBINED 1MIDDX. LYMPHOSARCOMA
GENERALIZED (TOTAL 104 )
LLJ
-J
1004
90
70
60
50
40
30
20
10
0
(13)
1 2 3 4 5
TIME IN YEARS
FIG. 9.-Five year survival curves of patients with generalised lymphosarcoma.
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When the disease was localised, the prognosis of all types was understandably
muchbetter(Fig. 10). Ofthe8patientswithlymphoblasticlymphosarcoma, 3have
survived 5years-a somewhat unexpected finding which suggeststheneedfor aless
pessimistic approach to this usually highly malignant disease. The 5 year survival
rate ofthe remaining 3 histological types was remarkably similar when the disease
was localised. In the original publication it was suggested that this feature
indicated that localised disease in these 3 groups was equally radiosensitive.
rMVH.
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FIG. 10.-Five year survival curves ofpatients with localised lymphosarcoma.
The 5 year survival rate is often severely criticised on the grounds that patients
with lymphosarcoma are never permanently cured. A more detailed examination
ofthe long-term survivors has therefore been carried out. The details ofpatients
surviving for 5 years or more, without clinicalevidence ofrecurrentlymphosarcoma
are summarised in Table III. All 21 patients referred to in this table have
remained alive and well with no clinical evidence oflymphosarcoma for periods of
5-20 years. Two patients have died: one, aged 71, had a cerebral haemorrhage
and another, aged 87, had a pulmonary embolus from a deep vein thrombosis.
Post-mortem examination ofthe second patient showed no lymphosarcoma. One
patient was lost to follow up after 11 years.
All except one patient in this group presented with localised disease. The
remaining 20 patients with localised disease have beenplacedinto the 4 histological
groups in Table IV, which also includes the number ofpatients surviving 5 years,
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TABLE III.-Analysis of 21 Patients who, Having Survived 5 Years Without Clinical
Evidence ofRecurrent Lymphosarcoma, Have Continued to Live NormalLivesfor
Periods of up to 20 Years
Histological group Patients
Nodular sclerotic
lymphosarcoma
Follicular
lymphoma
Diffuse
lymphosarcoma
Lymphoblastic
lymphosarcoma
MA
'
HB
FC
RW
VG
FH
GF
MA
RC
DG
NR
RD J
GF
MGl
MBI
WW
DYJ
WDJ
WB
JG
JCJ
Extent of
disease at
presentation
Localised
Localised
Generalised
Localised }
Localised }
Treatment
RT to affected areas '
RT to affected areas .
Local excision
RT to one area only .
RT to affected areas .
RT to affected areas .
Survival in years
8-D Cereb. haem. aged 71
14-AW
12-AW
11-AW
8-AW
9-AW
19-AW
17-AW
15-AW
14-AW
6-AW
5 4/12-AW
20-AW
8-AW
13-D Pulmonary emb.
11-lost to FU
5 6/12-AW
19-AW
17-AW
12-AW
11-AW
AW: Alive and well D: Dead FU: Follow up RT: Radiotherapy
TABLE IV.-Analysis ofPossible 5 Year and Long Term Survivors who
Presented with Localised Disease (see Table III)
Histological group
Nodular sclerotic lymphosarcoma .
Follicular lymphoma
Diffuse lymphosarcoma
Lymphoblastic lymphosarcoma
No. of pos-
sible 5 year
survivors
with
localised
lympho-
sarcoma
24
16
22
8
No. of 5 year
survivors
16
11
15
3
No. of
5 year
survivors
remaining
AW for
5-20 years
without
clinical
recurrence
8
4
5
3
% of 5 year
survivors
remaining AW
for 5-20 years
without clinical
recurrence
50%
37%
33%
100%
Note that one halfofthe 5 years survivors with nodular sclerotic lymphosarcoma continue without
recurrence up to 20 years compared with only one-third ofthe 5 year survivors in the diffuse lympho-
sarcoma group.
and the number ofpatients who have then continued to live normal lives without
recurrent disease for periods of from 5 to 20 years. Although the numbers are
small, the figures in the table suggest once again that nodular sclerotic lympho-
sarcoma is a disease of relatively low grade malignancy.
It is interesting to see that the very small number of patients with localised
lymphoblastic lymphosarcoma who survived 5 years have continued to live without
recurrence for long periods of time.
56
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TABLE V.-Analysis of 19 Patients who Presented in the First 2 Decades of Life
Extent of
disease at
Histological group Patients Age Sex presentation Survival in years
Lymphoblastic lymphosarcoma . SD 11 . M' . 7/12-AW
JF . 5 M . 7/12-D
MF . 17 . M . 3/12-D
BM 19 M > Generalised 3/12-D
MM. 16 .F . 9/12 AR
MK . 12 . M . 10/12-D
JG 17 M . 18days-D
GM 9 M Localised 4/12-AW
EC .14 M .6/12-D
Diffuse lymphosarcoma . EH 19 . M . 4 days-D
JJ 12 F F Generalised 156/12-D
MS .8 .Mi 3/12-D
RO . 16 . MJ . 10/12-D
MS . 19 . M Localised . 8 years-AW
Follicular lymphoma . . . GF . 19 . M Generalised 20 years-AW
RD 11 M Localised 5 4/12-AW
Nodular sclerotic lymphosarcoma . GF 9 M} Localised 19 years-AW
MA .8 .FJ 17 years-AW
AW: alive and well AR: alive with recurrence D: dead
Age.-Lymphosarcoma carries a very bad prognosis in the young. In the total
group of 233 patients, 19 were under the age of 20 (Table V). Ten had lympho-
blastic lymphosarcoma; 53% of this little group, compared with 17% of lympho-
blastic lymphosarcoma in the total group, confirming the high frequency of this
very malignant disease in the young. Of these 10 patients, 8 died within 1 year
and 2 still survive at 4 and 9 months. Five patients had diffuse lymphosarcoma
andthe only oneliving for more than 2 years was a localised case. The 4 remaining
patients had either follicular lymphoma ornodular sclerotic lymphosarcoma and all
4 remain free of recurrence for periods of 5 to 20 years.
DISCUSSION
The results ofthis investigation agree with the original findings of Bennett and
Millett (1969). The presence of fibrous banding within the lymphosarcomatous
lymph nodes indicates a greatly improved prognosis and an increased possibility of
permanent cure. This better prognosis is unrelated to the background pattern
which may be diffuse, follicular or a mixture ofboth, and appears to be independent
of the predominant cell type.
That this form of lymphosarcoma progresses at a lower tempo is confirmed by
several facts.
(1) When the disease was initially generalised, the 5 year survival rate was
better than with other types of lymphosarcoma.
(2) Withnodularsclerotic lymphosarcoma, alargenumber ofpatients presented
with localised disease.
(3) Although the 5 year survival rate is similar in all patients with localised
lymphosarcoma, except with the lymphoblastic form, a greater percentage of
patients with nodular sclerotic lymphosarcoma have remained alive and well,
clinically free from the disease for periods of 5 to 20 years.NODULAR SCLEROTIC LYMPHOSARCOMA
(4) In young people the prognosis in lymphosarcoma is usually appalling.
However, 2 patients with nodular sclerotic lymphosarcoma remain alive and well,
free from disease after 17 and 19 years.
(5) As a general rule, malignant lymphomas presenting with retro-peritoneal or
groin nodes are more difficult to control than when the disease presents in the
upper half of the body. Nodular sclerotic lymphosarcoma presents more com-
monly in the retroperitoneal and groin nodes, but in spite of this the prognosis is
better than with other forms of lymphosarcoma.
The fibrous banding diagnostic ofthis form oflymphosarcoma is presumably a
manifestation of host resistance to the disease and it is sometimes marked where
there is extranodal invasion of surrounding tissues. The better prognosis of
nodular sclerotic Hodgkin's disease (Lukes, 1966) is now generally accepted and it
is reasonable to expect that the fibrosis in this type oflymphosarcoma represents a
defence mechanism of a related type. The fibrosis may also be related to the
origin of the lymphoid tumour cells, as it is now recognised that lymphocytes
originating in the thymus or lymph node occupy different zones within a lymph
node. A more detailed study of the site and extent of the fibrosis in nodular
sclerotic lymphosarcoma appears to be indicated.
The number ofpatients in this combined series is still small and further investi-
gation of a larger series is necessary to confirm or refute the findings ofthis report,
and to assess the possible relationship between the dominant cell type and the
prognosis in nodular sclerotic lymphosarcoma.
From the study there emerge certain obvious facts related to the management
of patients with lymphosarcoma. It is now widely, but not universally, accepted
that Hodgkin's disease is not necessarily fatal and that with correct treatment
many patients can be cured (Peters, 1950; Jelliffe and Thomson, 1955; Easson and
Russell, 1963; Kaplan, 1968). Patients with lymphosarcoma must be considered
in a similar fashion. Manywill continue to dieoftheir disease in spite oftreatment,
but there is no place at all for half-hearted treatment due to the hopeless attitude
that is adopted almost universally by the medical profession. Thorough investiga-
tion is essential, after which correct, painstaking and sometimes energetic treat-
ment can be expected to cure an increasing number ofpatients. Nodular sclerotic
lymphosarcoma is a low grade form ofthe disease which is particularly amenable to
energetic treatment. However it must notbeforgotten that sometimes evenhighly
malignant lymphoblastic lymphosarcoma can be cured.
SUMMARY
A study of 233 patients with lyinphosarcoma arising primarily in the lymph
nodes is reported. When microscopical examination showed fibrous banding
within the lymph nodes, typical ofnodular sclerotic lymphosarcoma, the prognosis
was better than in the other histological groups. This improvement was more
marked in patients presenting with generalised disease, when treatment can be
expected to have less effect upon the outcome. With localised disease, the 5 year
survival rate was similar in follicular lymphoma, diffuse lymphosarcoma and
nodular sclerotic lymphosarcoma, but a greater percentage of the last type con-
tinue to survive, free from clinical evidence of disease, for periods up to 19 years.
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